Cargando…

Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis

BACKGROUND: Mounting evidence suggests that breast reduction surgery displays higher rates of surgical site infections (SSI) than initially presumed. Objective of this network meta-analysis is to evaluate the effectiveness of different antibiotic regimens in the prophylaxis from surgical site infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Seretis, Konstantinos, Bounas, Nikolaos, Papaspyrou, Foteini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229481/
https://www.ncbi.nlm.nih.gov/pubmed/36928312
http://dx.doi.org/10.1007/s00266-023-03313-2
_version_ 1785051266235236352
author Seretis, Konstantinos
Bounas, Nikolaos
Papaspyrou, Foteini
author_facet Seretis, Konstantinos
Bounas, Nikolaos
Papaspyrou, Foteini
author_sort Seretis, Konstantinos
collection PubMed
description BACKGROUND: Mounting evidence suggests that breast reduction surgery displays higher rates of surgical site infections (SSI) than initially presumed. Objective of this network meta-analysis is to evaluate the effectiveness of different antibiotic regimens in the prophylaxis from surgical site infections and delayed wound healing (DWH) following breast reduction. METHODS: A network meta-analysis was conducted using a predetermined protocol after searching the electronic databases MEDLINE, Scopus, the Cochrane Library and US National Institutes of Health Ongoing Trials Register from inception to July 2022. The included studies had to examine breast reduction in females with at least 1-month follow-up, receiving antibiotics in an intervention arm compared to a control arm. The quality of studies was assessed using the Cochrane risk of bias tool. A frequentist Mantel-Haenszel approach was adopted for the reported SSI rates while an inverse variance random effects model was used for the DWH rates. RESULTS: A total of 10 studies was included in the analysis involving 1331 patients. All but one study controlled for major risk factors, and no differences were observed in patients’ baseline characteristics. Antibiotic administration significantly reduced the SSI rate after breast reduction, with the prolonged antibiotic regimen being the most efficacious (odds ratio [OR]: 0.36 [95%CI: 0.15–0.85]). No statistically significant reduction in delayed wound healing rate was revealed among the regimens. CONCLUSIONS: Antibiotics mitigate the SSI rate after breast reduction. This meta-analysis provides an evidence-based strategy to optimize antibiotic administration. Further research is needed though to examine antibiotic prophylaxis on delayed wound healing. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00266-023-03313-2.
format Online
Article
Text
id pubmed-10229481
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-102294812023-06-01 Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis Seretis, Konstantinos Bounas, Nikolaos Papaspyrou, Foteini Aesthetic Plast Surg Review BACKGROUND: Mounting evidence suggests that breast reduction surgery displays higher rates of surgical site infections (SSI) than initially presumed. Objective of this network meta-analysis is to evaluate the effectiveness of different antibiotic regimens in the prophylaxis from surgical site infections and delayed wound healing (DWH) following breast reduction. METHODS: A network meta-analysis was conducted using a predetermined protocol after searching the electronic databases MEDLINE, Scopus, the Cochrane Library and US National Institutes of Health Ongoing Trials Register from inception to July 2022. The included studies had to examine breast reduction in females with at least 1-month follow-up, receiving antibiotics in an intervention arm compared to a control arm. The quality of studies was assessed using the Cochrane risk of bias tool. A frequentist Mantel-Haenszel approach was adopted for the reported SSI rates while an inverse variance random effects model was used for the DWH rates. RESULTS: A total of 10 studies was included in the analysis involving 1331 patients. All but one study controlled for major risk factors, and no differences were observed in patients’ baseline characteristics. Antibiotic administration significantly reduced the SSI rate after breast reduction, with the prolonged antibiotic regimen being the most efficacious (odds ratio [OR]: 0.36 [95%CI: 0.15–0.85]). No statistically significant reduction in delayed wound healing rate was revealed among the regimens. CONCLUSIONS: Antibiotics mitigate the SSI rate after breast reduction. This meta-analysis provides an evidence-based strategy to optimize antibiotic administration. Further research is needed though to examine antibiotic prophylaxis on delayed wound healing. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00266-023-03313-2. Springer US 2023-03-16 2023 /pmc/articles/PMC10229481/ /pubmed/36928312 http://dx.doi.org/10.1007/s00266-023-03313-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Seretis, Konstantinos
Bounas, Nikolaos
Papaspyrou, Foteini
Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis
title Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis
title_full Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis
title_fullStr Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis
title_full_unstemmed Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis
title_short Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis
title_sort antibiotic prophylaxis in reduction mammaplasty: a network meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229481/
https://www.ncbi.nlm.nih.gov/pubmed/36928312
http://dx.doi.org/10.1007/s00266-023-03313-2
work_keys_str_mv AT seretiskonstantinos antibioticprophylaxisinreductionmammaplastyanetworkmetaanalysis
AT bounasnikolaos antibioticprophylaxisinreductionmammaplastyanetworkmetaanalysis
AT papaspyroufoteini antibioticprophylaxisinreductionmammaplastyanetworkmetaanalysis